HEADER HYDROLASE/HYDROLASE INHIBITOR 18-MAY-11 3S45 TITLE WILD-TYPE HIV-2 PROTEASE WITH ANTIVIRAL DRUG AMPRENAVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 514-612; COMPND 5 EC: 3.4.23.47; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 2; SOURCE 3 ORGANISM_TAXID: 11709; SOURCE 4 STRAIN: 11720; SOURCE 5 GENE: POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS AMPRENAVIR, HIV/AIDS, DRUG RESISTANCE, ASPARTIC PROTEASE, MOLECULAR KEYWDS 2 RECOGNITION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.-F.TIE,Y.-F.WANG,I.T.WEBER REVDAT 2 13-SEP-23 3S45 1 REMARK LINK REVDAT 1 21-MAR-12 3S45 0 JRNL AUTH Y.TIE,Y.F.WANG,P.I.BOROSS,T.Y.CHIU,A.K.GHOSH,J.TOZSER, JRNL AUTH 2 J.M.LOUIS,R.W.HARRISON,I.T.WEBER JRNL TITL CRITICAL DIFFERENCES IN HIV-1 AND HIV-2 PROTEASE SPECIFICITY JRNL TITL 2 FOR CLINICAL INHIBITORS. JRNL REF PROTEIN SCI. V. 21 339 2012 JRNL REFN ISSN 0961-8368 JRNL PMID 22238126 JRNL DOI 10.1002/PRO.2019 REMARK 2 REMARK 2 RESOLUTION. 1.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.187 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.183 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1282 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 25801 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.163 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.160 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1046 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 20949 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1510 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1669.7 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 8 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 15542 REMARK 3 NUMBER OF RESTRAINTS : 19854 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 ANGLE DISTANCES (A) : 0.026 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.039 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.052 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.008 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.036 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.072 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CONJUGAGE GRADIENT MINIMIZATION REMARK 4 REMARK 4 3S45 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000065737. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25917 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.510 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.3 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.25500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3EBZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M NACL, 0.6 M IMIDAZOLE/0.12 M REMARK 280 ZINC ACETATE BUFFER AT PH 6.0. 30% GLYCEROL AS CRYOPROTECTOR, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 52.99900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 15.49300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 52.99900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 15.49300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1001 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1002 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 99 CL CL A 513 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR B 42 CB - CG - CD1 ANGL. DEV. = 4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 501 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 41 OD1 REMARK 620 2 HOH A1054 O 75.1 REMARK 620 3 HOH A1083 O 83.9 64.2 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 536 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 65 OE1 REMARK 620 2 IMD A 526 N3 113.7 REMARK 620 3 HOH A1001 O 94.8 108.3 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 533 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LEU A 99 O REMARK 620 2 IMD A 524 N3 73.0 REMARK 620 3 HOH A1080 O 91.8 161.2 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 531 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 21 OE2 REMARK 620 2 IMD B 521 N3 112.9 REMARK 620 3 IMD B 522 N3 95.6 118.4 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 532 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 30 OD2 REMARK 620 2 IMD B 523 N3 105.8 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 537 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 65 OE1 REMARK 620 2 HOH B1007 O 74.8 REMARK 620 3 HOH B1013 O 117.5 107.0 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 513 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 524 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 526 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 533 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 535 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 536 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 478 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 511 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 512 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 514 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 515 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 516 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 517 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 518 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD B 521 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD B 522 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD B 523 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD B 525 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 531 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 532 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 534 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 537 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3NU3 RELATED DB: PDB REMARK 900 WIDE-TYPE HIV1 PROTEASE WITH AMPRENAVIR REMARK 900 RELATED ID: 3EBZ RELATED DB: PDB REMARK 900 WIDE-TYPE HIV2 PROTEASE WITH DARUNAVIR REMARK 900 RELATED ID: 3ECG RELATED DB: PDB REMARK 900 WIDE-TYPE HIV2 PROTEASE WITH INHIBITOR GRL-98065 REMARK 900 RELATED ID: 3EC0 RELATED DB: PDB REMARK 900 WIDE-TYPE HIV2 PROTEASE WITH INHIBITOR GRL-06579A DBREF 3S45 A 1 99 UNP Q9W9R3 Q9W9R3_9HIV2 1 99 DBREF 3S45 B 1 99 UNP Q9W9R3 Q9W9R3_9HIV2 1 99 SEQRES 1 A 99 PRO GLN PHE SER LEU TRP LYS ARG PRO VAL VAL THR ALA SEQRES 2 A 99 TYR ILE GLU GLY GLN PRO VAL GLU VAL LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP SER ILE VAL ALA GLY ILE GLU LEU GLY SEQRES 4 A 99 ASN ASN TYR SER PRO LYS ILE VAL GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE ASN THR LYS GLU TYR LYS ASN VAL GLU ILE GLU SEQRES 6 A 99 VAL LEU ASN LYS LYS VAL ARG ALA THR ILE MET THR GLY SEQRES 7 A 99 ASP THR PRO ILE ASN ILE PHE GLY ARG ASN ILE LEU THR SEQRES 8 A 99 ALA LEU GLY MET SER LEU ASN LEU SEQRES 1 B 99 PRO GLN PHE SER LEU TRP LYS ARG PRO VAL VAL THR ALA SEQRES 2 B 99 TYR ILE GLU GLY GLN PRO VAL GLU VAL LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP SER ILE VAL ALA GLY ILE GLU LEU GLY SEQRES 4 B 99 ASN ASN TYR SER PRO LYS ILE VAL GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE ASN THR LYS GLU TYR LYS ASN VAL GLU ILE GLU SEQRES 6 B 99 VAL LEU ASN LYS LYS VAL ARG ALA THR ILE MET THR GLY SEQRES 7 B 99 ASP THR PRO ILE ASN ILE PHE GLY ARG ASN ILE LEU THR SEQRES 8 B 99 ALA LEU GLY MET SER LEU ASN LEU HET NA A 501 1 HET CL A 513 1 HET IMD A 524 5 HET IMD A 526 5 HET ZN A 533 1 HET ZN A 535 1 HET ZN A 536 1 HET 478 B 201 35 HET CL B 511 1 HET CL B 512 1 HET CL B 514 1 HET CL B 515 1 HET CL B 516 1 HET CL B 517 1 HET CL B 518 1 HET IMD B 521 5 HET IMD B 522 5 HET IMD B 523 5 HET IMD B 525 5 HET ZN B 531 1 HET ZN B 532 1 HET ZN B 534 1 HET ZN B 537 1 HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM IMD IMIDAZOLE HETNAM ZN ZINC ION HETNAM 478 {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL- HETNAM 2 478 2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL HETNAM 3 478 ESTER HETSYN 478 AMPRENAVIR FORMUL 3 NA NA 1+ FORMUL 4 CL 8(CL 1-) FORMUL 5 IMD 6(C3 H5 N2 1+) FORMUL 7 ZN 7(ZN 2+) FORMUL 10 478 C25 H35 N3 O6 S FORMUL 26 HOH *98(H2 O) HELIX 1 1 GLY A 86 LEU A 93 1 8 HELIX 2 2 GLY B 86 GLY B 94 1 9 SHEET 1 A 4 GLN A 2 PHE A 3 0 SHEET 2 A 4 SER B 96 ASN B 98 -1 O LEU B 97 N PHE A 3 SHEET 3 A 4 SER A 96 ASN A 98 -1 N ASN A 98 O SER B 96 SHEET 4 A 4 GLN B 2 PHE B 3 -1 O PHE B 3 N LEU A 97 SHEET 1 B 8 SER A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 VAL A 66 -1 O THR A 56 N LYS A 45 SHEET 3 B 8 LYS A 69 GLY A 78 -1 O VAL A 71 N ILE A 64 SHEET 4 B 8 ILE A 32 VAL A 33 1 N VAL A 33 O MET A 76 SHEET 5 B 8 ILE A 84 PHE A 85 -1 O ILE A 84 N ILE A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O PHE A 85 SHEET 7 B 8 VAL A 10 ILE A 15 -1 N VAL A 11 O VAL A 22 SHEET 8 B 8 GLY A 52 VAL A 66 -1 O GLU A 65 N TYR A 14 SHEET 1 C 8 SER B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 VAL B 66 -1 O GLU B 58 N SER B 43 SHEET 3 C 8 LYS B 69 THR B 77 -1 O ILE B 75 N TYR B 59 SHEET 4 C 8 ILE B 32 VAL B 33 1 N VAL B 33 O MET B 76 SHEET 5 C 8 ILE B 84 PHE B 85 -1 O ILE B 84 N ILE B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O PHE B 85 SHEET 7 C 8 VAL B 10 ILE B 15 -1 N VAL B 11 O VAL B 22 SHEET 8 C 8 GLY B 52 VAL B 66 -1 O GLU B 65 N TYR B 14 LINK OD1 ASN A 41 NA NA A 501 1555 1555 2.11 LINK OE1 GLU A 65 ZN ZN A 536 1555 1555 2.21 LINK OD2 ASP A 79 ZN ZN A 535 1555 1555 1.90 LINK O LEU A 99 ZN ZN A 533 1555 1555 2.63 LINK NA NA A 501 O HOH A1054 1555 1555 3.00 LINK NA NA A 501 O HOH A1083 1555 1555 2.59 LINK N3 IMD A 524 ZN ZN A 533 1555 1555 2.63 LINK N3 IMD A 526 ZN ZN A 536 1555 1555 1.78 LINK ZN ZN A 533 O HOH A1080 1555 1555 2.65 LINK ZN ZN A 536 O HOH A1001 1555 1555 2.21 LINK OE2 GLU B 21 ZN ZN B 531 1555 1555 1.95 LINK OD2 ASP B 30 ZN ZN B 532 1555 1555 1.91 LINK OE1 GLU B 65 ZN ZN B 537 1555 1555 1.70 LINK N3 IMD B 521 ZN ZN B 531 1555 1555 2.06 LINK N3 IMD B 522 ZN ZN B 531 1555 1555 1.75 LINK N3 IMD B 523 ZN ZN B 532 1555 1555 2.28 LINK N3 IMD B 525 ZN ZN B 534 1555 1555 2.33 LINK ZN ZN B 537 O HOH B1007 1555 1555 2.18 LINK ZN ZN B 537 O HOH B1013 1555 1555 1.72 SITE 1 AC1 6 ASN A 40 ASN A 41 PRO A 44 HOH A1054 SITE 2 AC1 6 HOH A1083 ASN B 40 SITE 1 AC2 5 SER A 4 LEU A 99 IMD A 524 ZN A 533 SITE 2 AC2 5 HOH A1080 SITE 1 AC3 6 GLN A 2 PHE A 3 LEU A 99 CL A 513 SITE 2 AC3 6 ZN A 533 PRO B 1 SITE 1 AC4 5 TYR A 14 GLY A 17 GLU A 65 ZN A 536 SITE 2 AC4 5 HOH A1002 SITE 1 AC5 5 LYS A 7 LEU A 99 CL A 513 IMD A 524 SITE 2 AC5 5 HOH A1080 SITE 1 AC6 2 ASP A 79 GLU B 37 SITE 1 AC7 4 GLU A 65 IMD A 526 HOH A1001 HOH A1002 SITE 1 AC8 19 ASP A 25 GLY A 27 ALA A 28 ASP A 30 SITE 2 AC8 19 ILE A 32 GLY A 49 ILE A 50 ILE A 82 SITE 3 AC8 19 ILE A 84 ASP B 25 GLY B 27 ALA B 28 SITE 4 AC8 19 ASP B 29 ASP B 30 GLY B 48 GLY B 49 SITE 5 AC8 19 ILE B 50 ILE B 84 HOH B1003 SITE 1 AC9 7 VAL B 11 THR B 12 LYS B 45 ILE B 46 SITE 2 AC9 7 IMD B 523 HOH B1043 HOH B1073 SITE 1 BC1 6 LYS B 7 ASP B 30 GLY B 48 CL B 517 SITE 2 BC1 6 IMD B 523 ZN B 532 SITE 1 BC2 2 GLU B 65 ZN B 537 SITE 1 BC3 5 SER B 4 LEU B 5 TRP B 6 LYS B 7 SITE 2 BC3 5 ZN B 534 SITE 1 BC4 3 CL B 518 IMD B 525 ZN B 534 SITE 1 BC5 5 ASP B 29 ASP B 30 CL B 512 IMD B 523 SITE 2 BC5 5 ZN B 532 SITE 1 BC6 3 ARG A 8 CL B 516 ZN B 534 SITE 1 BC7 7 GLU B 21 ILE B 46 PHE B 53 ASN B 55 SITE 2 BC7 7 ASP B 79 IMD B 522 ZN B 531 SITE 1 BC8 4 GLU B 21 ASP B 79 IMD B 521 ZN B 531 SITE 1 BC9 7 ASP B 30 ILE B 46 MET B 76 CL B 511 SITE 2 BC9 7 CL B 512 CL B 517 ZN B 532 SITE 1 CC1 6 ARG A 8 PRO A 81 TRP B 6 CL B 516 SITE 2 CC1 6 ZN B 534 HOH B1051 SITE 1 CC2 4 GLU B 21 ASP B 79 IMD B 521 IMD B 522 SITE 1 CC3 4 ASP B 30 CL B 512 CL B 517 IMD B 523 SITE 1 CC4 4 CL B 515 CL B 516 CL B 518 IMD B 525 SITE 1 CC5 4 GLU B 65 CL B 514 HOH B1007 HOH B1013 CRYST1 105.998 30.986 56.161 90.00 91.66 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009434 0.000000 0.000273 0.00000 SCALE2 0.000000 0.032273 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017813 0.00000